Position in LLY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$17,873,906
+$5,270,300 QoQ
Shares Held
14,902
+8.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.11%
of 13F equity value
Holder Rank
#945
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026WESTPAC BANKING CORP holds $68,686,791 across 9 Drug Manufacturers - General names. LLY ranks #1 (26.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
14,902 | $17,873,906 | |
| 2 | JNJ |
Johnson & Johnson
|
43,862 | $11,139,631 | |
| 3 | AMGN |
Amgen Inc
|
28,767 | $10,417,105 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
78,465 | $9,913,266 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
170,319 | $9,813,779 | |
| 6 | MRK |
Merck & Co., Inc.
|
33,068 | $4,249,237 | |
| 7 | ABBV |
AbbVie Inc.
|
9,928 | $2,498,281 | |
| 8 | PFE |
Pfizer Inc
|
98,978 | $2,383,388 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,873,906 | 14,902 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $12,603,606 | 13,703 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $15,284,099 | 14,222 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $7,776,496 | 10,192 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $11,362,429 | 14,576 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $14,730,929 | 17,836 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $20,107,512 | 26,046 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $25,580,629 | 28,874 | Shares | Defined | 2024-11-08 | |
| 2024-06-30 | $20,872,629 | 23,054 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $16,869,283 | 21,684 | Shares | Defined | 2024-05-09 | |
| 2023-12-31 | $13,483,522 | 23,131 | Shares | Defined | 2024-02-08 | |
| 2023-09-30 | $21,859,041 | 40,696 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $13,715,788 | 29,246 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $60,715,965 | 176,798 | Shares | Defined | 2023-05-04 | |
| 2022-12-31 | $56,544,227 | 154,560 | Shares | Defined | 2023-02-06 | |
| 2022-09-30 | $51,128,745 | 158,122 | Shares | Defined | 2022-11-08 | |
| 2022-06-30 | $48,775,211 | 150,434 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $45,368,448 | 158,426 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $55,990,064 | 202,701 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $56,164,554 | 243,084 | Shares | Defined | 2021-10-27 | |
| 2021-06-30 | $70,460,111 | 306,989 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $65,728,128 | 351,826 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $36,391,259 | 215,537 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $20,258,900 | 136,866 | Shares | Defined | 2020-11-10 | |
| 2020-06-30 | $21,534,664 | 131,165 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $20,130,348 | 145,115 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||